Keith M. Gottesdiener
2017
In 2017, Keith M. Gottesdiener earned a total compensation of $1.5M as President and Chief Executive Officer, Director at RHYTHM PHARMACEUTICALS, a 173% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,398 |
|---|---|
| Option Awards | $799,994 |
| Salary | $490,795 |
| Total | $1,536,187 |
Gottesdiener received $800K in option awards, accounting for 52% of the total pay in 2017.
Gottesdiener also received $245.4K in non-equity incentive plan and $490.8K in salary.
Rankings
In 2017, Keith M. Gottesdiener's compensation ranked 6,844th out of 14,666 executives tracked by ExecPay. In other words, Gottesdiener earned more than 53.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,844 out of 14,666 | 53rd |
Division Manufacturing | 2,536 out of 5,772 | 56th |
Major group Chemicals And Allied Products | 820 out of 2,075 | 61st |
Industry group Drugs | 634 out of 1,731 | 63rd |
Industry Pharmaceutical Preparations | 500 out of 1,333 | 63rd |
Source: SEC filing on April 30, 2018.
Gottesdiener's colleagues
We found two more compensation records of executives who worked with Keith M. Gottesdiener at RHYTHM PHARMACEUTICALS in 2017.